UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 844

Sortiert nach

Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy

Annals of oncology, 2020-06, Vol.31 (6), p.724-744

2020

Link zum Volltext

Verfügbarkeit prüfen

Skin toxicity and efficacy of sunitinib and sorafenib in metastatic renal cell carcinoma: a national registry-based study

Annals of oncology, 2012-12, Vol.23 (12), p.3137-3143

2012

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of 5-arylacetylenyl-1,2,4-oxadiazoles and their transformations under superelectrophilic activation conditions

Beilstein journal of organic chemistry, 2021-09, Vol.17 (1), p.2417-2424

2021

Link zum Volltext

Verfügbarkeit prüfen

Melanoma antigens are biomarkers for ipilimumab response

Journal of the European Academy of Dermatology and Venereology, 2017-02, Vol.31 (2), p.252-259

2017

Link zum Volltext

Verfügbarkeit prüfen

Protective Coatings Based on Titanium Diboride and Carbon Fillers

Protection of metals and physical chemistry of surfaces, 2023-08, Vol.59 (4), p.638-647

2023

Link zum Volltext

Verfügbarkeit prüfen

A Study of Metal-Powder Alloy KhN56KVMTYuB for GTE Disks Under Aggressive Impact of Sodium Chlorides and Sulfates

Metal science and heat treatment, 2021-11, Vol.63 (7-8), p.363-368

2021

Link zum Volltext

Verfügbarkeit prüfen

Stability of Foam-Silicate Aggregates Against Alkali in Cement

Glass and ceramics, 2018-01, Vol.74 (9-10), p.372-377

2018

Link zum Volltext

Verfügbarkeit prüfen

Crystallization of the Amorphous Phase in Foam Glass as a Method of Decreasing the Alkali-Silicon Reaction

Glass and ceramics, 2016-07, Vol.73 (3-4), p.77-81

2016

Link zum Volltext

Verfügbarkeit prüfen

Intratumoral (IT) Injection of the TLR9 agonist tilsotolimod (IMO-2125) in combination with ipilimumab (ipi) triggers durable responses in PD-1 inhibitor refractory metastatic melanoma (rMM): Results from a multicenter, phase I/II study

Annals of oncology, 2018-10, Vol.29, p.viii442-viii442

2018

Link zum Volltext

Verfügbarkeit prüfen

Neural Net Modeling of Checkpoint Inhibitor Related Myocarditis and Steroid Response

Clinical pharmacology: advances and applications, 2022-01, Vol.14, p.69-90

2022

Link zum Volltext

Verfügbarkeit prüfen

3340 Treatment beyond progression in advanced BRAF-mutated melanoma with vemurafenib and cobimetinib: Results from the BRIM7 trial

European journal of cancer (1990), 2015-09, Vol.51, p.S679-S679

2015

Link zum Volltext

Verfügbarkeit prüfen

3330 Clinical benefits associated with durable response (DR) in patients (pts) with unresected stage IIIB/C/IV melanoma treated with talimogene laherparepvec (T-VEC) or GM-CSF in the randomized phase 3 OPTiM trial (NCT00769704)

European journal of cancer (1990), 2015-09, Vol.51, p.S674-S674

2015

Link zum Volltext

Verfügbarkeit prüfen

Development of chronic lymphocytic leukaemia during ipilimumab therapy in a patient with metastatic melanoma

Journal of the European Academy of Dermatology and Venereology, 2016-09, Vol.30 (9), p.1626-1627

2016

Link zum Volltext

Verfügbarkeit prüfen

A Phase 1 Trial of Concurrent Sorafenib and Stereotactic Radiosurgery for Patients With 1-4 Brain Metastases

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S326-S327

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of baseline serum lactate dehydrogenase concentration on the efficacy of pembrolizumab and ipilimumab in patients with advanced melanoma: data from KEYNOTE-006

EUROPEAN JOURNAL OF CANCER, 2017, Vol.72, p.S122-S123

2017

Link zum Volltext

Verfügbarkeit prüfen

Development and Industrial Tests of the TiB2-Based Composite Material for Local Fractures Repairing of Electrolyzer Bottom Blocks

Russian journal of non-ferrous metals, 2019-07, Vol.60 (4), p.348-353

2019

Link zum Volltext

Verfügbarkeit prüfen

3334 Durable complete responses (CR) in patients (pts) with stage IIIB-IV melanoma treated with talimogene laherparepvec (T-VEC) in OPTiM

European journal of cancer (1990), 2015-09, Vol.51, p.S676-S676

2015

Link zum Volltext

Verfügbarkeit prüfen

24LBA Safety data from the phase 1b part of the MASTERKEY-265 study combining talimogene laherparepvec (T-VEC) and pembrolizumab for unresectable stage IIIB-IV melanoma

European journal of cancer (1990), 2015-09, Vol.51, p.S722-S722

2015

Link zum Volltext

Verfügbarkeit prüfen

354 Phase I study of investigational oral mTORC1/2 inhibitor MLN0128: Expansion phase in patients with renal, endometrial, or bladder cancer

European journal of cancer (1990), 2015-09, Vol.51, p.S72-S72

2015

Link zum Volltext

Verfügbarkeit prüfen

A Phase 1 Trial of Concurrent Sorafenib and Stereotactic Radiosurgery for Patients With 1-4 Brain Metastases

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S271-S271

2013

Link zum Volltext

Verfügbarkeit prüfen

Mössbauer Study of Amorphous Films Deposited from Solutions of Halide-Chalcogenide Glasses in n-Butylamine

Glass physics and chemistry, 2022-10, Vol.48 (5), p.400-402

2022

Link zum Volltext

Verfügbarkeit prüfen

270 The Impact of a Tissue Acquisition Program On Research in Molecular Targeted Therapy of Melanoma

European journal of cancer (1990), 2012-11, Vol.48, p.83-83

2012

Link zum Volltext

Verfügbarkeit prüfen

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

The New England journal of medicine, 2015-08, Vol.373 (8), p.726-736

2015

Link zum Volltext

Verfügbarkeit prüfen

IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells

The Journal of immunology (1950), 1996-11, Vol.157 (10), p.4282

1996

Link zum Volltext

Verfügbarkeit prüfen

Distribution of chloride ions along the flight path of aircraft (Overview)

Journal of physics. Conference series, 2022-12, Vol.2373 (2), p.22008

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 844

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(723)
Mit Volltextzugriff
(749)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(123)
Journal For Immunotherapy Of Cancer
(38)
Annals Of Oncology
(34)
Journal Of Translational Medicine
(31)
Clinical Cancer Research
(21)
Cancer Research
(17)
European Journal Of Cancer
(16)
Semiconductors
(15)
Atomic Energy
(12)
Problemy Tuberkuleza
(11)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy

Skin toxicity and efficacy of sunitinib and sorafenib in metastatic renal cell carcinoma: a national registry-based study

Synthesis of 5-arylacetylenyl-1,2,4-oxadiazoles and their transformations under superelectrophilic activation conditions

Melanoma antigens are biomarkers for ipilimumab response

Protective Coatings Based on Titanium Diboride and Carbon Fillers

A Study of Metal-Powder Alloy KhN56KVMTYuB for GTE Disks Under Aggressive Impact of Sodium Chlorides and Sulfates

Stability of Foam-Silicate Aggregates Against Alkali in Cement

Crystallization of the Amorphous Phase in Foam Glass as a Method of Decreasing the Alkali-Silicon Reaction

Intratumoral (IT) Injection of the TLR9 agonist tilsotolimod (IMO-2125) in combination with ipilimumab (ipi) triggers durable responses in PD-1 inhibitor refractory metastatic melanoma (rMM): Results from a multicenter, phase I/II study

Neural Net Modeling of Checkpoint Inhibitor Related Myocarditis and Steroid Response

3340 Treatment beyond progression in advanced BRAF-mutated melanoma with vemurafenib and cobimetinib: Results from the BRIM7 trial

3330 Clinical benefits associated with durable response (DR) in patients (pts) with unresected stage IIIB/C/IV melanoma treated with talimogene laherparepvec (T-VEC) or GM-CSF in the randomized phase 3 OPTiM trial (NCT00769704)

Development of chronic lymphocytic leukaemia during ipilimumab therapy in a patient with metastatic melanoma

A Phase 1 Trial of Concurrent Sorafenib and Stereotactic Radiosurgery for Patients With 1-4 Brain Metastases

Impact of baseline serum lactate dehydrogenase concentration on the efficacy of pembrolizumab and ipilimumab in patients with advanced melanoma: data from KEYNOTE-006

Development and Industrial Tests of the TiB2-Based Composite Material for Local Fractures Repairing of Electrolyzer Bottom Blocks

3334 Durable complete responses (CR) in patients (pts) with stage IIIB-IV melanoma treated with talimogene laherparepvec (T-VEC) in OPTiM

24LBA Safety data from the phase 1b part of the MASTERKEY-265 study combining talimogene laherparepvec (T-VEC) and pembrolizumab for unresectable stage IIIB-IV melanoma

354 Phase I study of investigational oral mTORC1/2 inhibitor MLN0128: Expansion phase in patients with renal, endometrial, or bladder cancer

A Phase 1 Trial of Concurrent Sorafenib and Stereotactic Radiosurgery for Patients With 1-4 Brain Metastases

Mössbauer Study of Amorphous Films Deposited from Solutions of Halide-Chalcogenide Glasses in n-Butylamine

270 The Impact of a Tissue Acquisition Program On Research in Molecular Targeted Therapy of Melanoma

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells

Distribution of chloride ions along the flight path of aircraft (Overview)

Suchergebnisse filtern